Recent report claims that SC66 had significant anti-tumor effects on hepatocellular carcinoma cells through producing ROS, subsequently inducing anoikis-mediated cell death and inhibiting the AKT signaling pathway [8]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.